Top Markets
#1 Gama Token Gama Token +9.13%
#2 Audiera Audiera +4.59%
#3 Cross Cross +4.58%
#4 Ribbita by Virtuals Ribbita by Virtuals +3.14%
#5 OKZOO OKZOO +2.26%
#6 Humanity Humanity +2.23%
#7 Quack AI Quack AI +2.19%
#8 Akedo Akedo +2.08%
#9 Fabric Protocol Fabric Protocol +1.82%
#10 Kinesis Gold Kinesis Gold +1.82%
Coin of the day
Gama Token Gama Token
Settings
Language
ENGLISH
Currency
USD
Theme
Medican Enterprises, Inc. Medican Enterprises, Inc.

Medican Enterprises, Inc.

MDCN
Rank in Stocks #36247
Medican Enterprises, Inc. is a bio-pharmaceutical company, which engages in the... Medican Enterprises, Inc. is a bio-pharmaceutical company, which engages in the production, cultivation, and wholesale distribution of cannabis related products. The company was founded on October 27, 1988 and is headquartered in Los Angeles, CA.
Share Price
$0.0001
Last synced: 2026-08-13
Market Cap
$2.88M
Change (1 day)
0.00%
Change (1 year)
0.00%
Country
US
Trade Medican Enterprises, Inc. (MDCN)

Category

Healthcare
Earnings for Medican Enterprises, Inc. (MDCN)
Earnings in 2026 TTM: 0
According to Medican Enterprises, Inc. latest financial reports the company's current earnings are 0. In 2026 the company made an earning of 0, equal to its 2026 earnings that were of 0. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Earnings history for Medican Enterprises, Inc. from 2026 to 2026
Earnings at the end of each year
Year Earnings Change
Not enough data for the provided dates.
Earnings for similar companies or competitors
Company Earnings Earnings Difference Country
Royalty Pharma plc Royalty Pharma plc
Royalty Pharma plc
RPRX.US
$1.35B -
US
Swedish Orphan Biovitrum AB Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB
SOBI.ST
- -
SE
Ipsen S.A. Ipsen S.A.
Ipsen S.A.
IPN.PA
- -
FR
Recordati Industria Chimica e Farmaceutica S.p.A. Recordati Industria Chimica e Farmaceutica S.p.A.
Recordati Industria Chimica e Farmaceutica S.p.A.
REC.MI
- -
IT
Corcept Therapeutics Incorporated Corcept Therapeutics Incorporated
Corcept Therapeutics Incorporated
CORT.US
$26.37M -
US